The biological anakinra appears promising to halt cytokine storm syndrome seen in severe courses of COVID-19. However, immunosuppression with anakinra may facilitate sepsis, necessitating continuous screening for bacterial superinfections.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752410 | PMC |
http://dx.doi.org/10.1002/ccr3.3307 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!